CCNB1 and nasopharyngeal carcinoma: For example, the chemosensitivity of nasopharyngeal cancer (NPC) cells to cisplatin was boosted by metformin or cucurbitacin E, which inhibited the DRP1 upstream kinase AMPK or cyclin B1/Cdk1 [464].